Neuro Event Labs OY

Neuro Event Labs OY

Medical Imaging & Radiology

About Neuro Event Labs OY

Neuro Event Labs is a global healthcare diagnostics company pioneering AI motion diagnostics for epilepsy monitoring. The company's flagship product, Nelli®, is the world's first non-contact, AI-driven video and audio monitoring system designed to identify and prioritize the review of seizure events with positive motor components. Nelli analyzes audio/video recordings captured via a Personal Recording Unit (PRU) with camera and microphone to identify events indicative of motor seizures. The system uses machine learning algorithms to detect relevant moments, creating an interactive report for physician review. Neuro Event Labs also offers an optional service for expert review by credentialed clinical staff. The technology has demonstrated 88% sensitivity for all motor seizures and 95.2% sensitivity for convulsive seizures in European in-hospital validation studies. Nelli is FDA 510(k) cleared for use in the United States, CE marked as a Class IIa medical device in the European Union under MDR, and registered as a Class IIa device in the United Kingdom. The system serves both hospital and at-home monitoring environments, enhancing current diagnostic and follow-up methods for epilepsy patients. Neuro Event Labs has received funding from the European Union's Horizon 2020 research and innovation programme and has established partnerships with leading epilepsy centers including Newcastle Royal Victoria Infirmary and Filadelfia Epilepsy Hospital in Denmark.

Mission & Story

Mission

Neuro Event Labs helps epilepsy patients and their doctors through technology

Clinical Focus

Medical conditions and clinical areas addressed by Neuro Event Labs OY.

epilepsyseizuresmotor seizuresconvulsive seizurespharmacoresistant epilepsy

Who It Serves

Health SystemsHospitalsEpilepsy CentersClinics

Milestones & Awards

Recent Milestones

FDA 510(k) clearance November 2025, €2.0M funding round February 2025, EU MDR certification December 2024, Newcastle Royal Victoria Infirmary partnership March 2026, FDA Breakthrough Device Designation

Awards & Recognition

FDA Breakthrough Device Designation, first seizure detection device to achieve EU MDR compliance, featured in Epilepsy Professional Magazine by Epilepsy Action

Key Partnerships

Newcastle Royal Victoria InfirmaryFiladelfia Epilepsy Hospital DenmarkDanish Epilepsy Centre DianalundLinköping University HospitalCornwall UK healthcare facilities

Social & Media

Company Details

Headquarters
Tampere, Finland
Employees
1-10

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Security & Compliance

FDA 510(k)CE Mark MDR Class IIaUK MDR Class IIa
Last updated Jun 30, 2026

Similar Companies in this Market

View all 189
A2z Radiology Ai

A2z Radiology Ai

AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.

Adas3D Medical S.L

Adas3D Medical S.L

11-50 employees

Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.

AEYE Health

AEYE Health

11-50 employees

AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.

Agfa HealthCare N.V.

Agfa HealthCare N.V.

AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.

AI4MedImaging Medical Solutions

AI4MedImaging Medical Solutions

AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.

Aidence

Aidence

Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.

Aidoc

Aidoc

growth · 350 employees

Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.

Aikenist Technologies Pvt Ltd

Aikenist Technologies Pvt Ltd

21-100 employees

Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.